First, they suggest that AOD-9604 can be used for extended periods without loss of efficacy due to antibody neutralization
More widespread use of SGLT2i in type 1 diabetes will necessitate implementation of strategies to assess and mitigate DKA risk, including preventative measures, patient education and continuous ketone monitoring, as well as a better understanding of the potential benefits for clinical cardiorenal outcomes, especially in high-risk populations such as people with CKD (Table 2) [46, 47]
Molecules 2010, 15, 1260 View Abstract [21] Vogel, J.U
"The sheer cost of these medications is a huge barrier to access," he said in a call with reporters
If you're on the fence, just try it
You should also know that there are many people around the world who fast much longer than 14 hours, some even 22 hours (ref)